Home/Filings/4/0001209191-18-046402
4//SEC Filing

Duchemin Jeffrey 4

Accession 0001209191-18-046402

CIK 0001123494other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:09 PM ET

Size

5.8 KB

Accession

0001209191-18-046402

Insider Transaction Report

Form 4
Period: 2018-08-03
Duchemin Jeffrey
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2018-08-03$5.70/sh12,619$71,928742,249 total
Footnotes (2)
  • [F1]The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person on August 3, 2015.
  • [F2]Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (c) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (d) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (e) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; and (f) 122,097 shares of common stock held by the Reporting Person.

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeother

Related Parties

1
  • filerCIK 0001585223

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:09 PM ET
Size
5.8 KB